Siden Research Team

MeSH: Medical Marijuana/ae [Adverse Effects]

Complexity of Medication Regimens for Children With Neurological Impairment
Jan 8, 2025
—
by
Siden Research Team
BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental condition estimated to affect 1 in 66 children in Canada and 1 in 270 individuals worldwide. As effective therapies for the management of ASD core and associated symptoms are limited, parents are increasingly turning to clinicians for advice regarding the use of medicinal cannabis to manage behavioural…
Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study
Jan 6, 2025
—
by
Siden Research Team
BACKGROUND: Cannabis is legal for recreational and medical use in Canada. Our aim was to explore family experiences using medical cannabis for children with severe conditions in the context of legalization. METHODS: We conducted a qualitative study using semistructured interviews between April and July 2019. Participants were parents of children attending BC Children’s Hospital oncology…